Anticoagulants and the formation of lymphocysts after pelvic lymphadenectomy in gynecologic and oncologic operations.
The incidence of lymphocysts was compared in two groups of patients treated by simple or radical hysterectomy including pelvic lymphadenectomy for carcinoma of the cervix and endometrium. Promoting factors for the formation of lymphocysts and the relation with thrombosis and prophylaxis are discussed.
H
H
Kragt
J
J
Bouma
J G
JG
Aalders
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D003374:Coumarins / Q000008:administration & dosage; D003911:Dextrans / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007044:Hysterectomy / Q000379:methods; D008197:Lymph Node Excision / Q000379:methods*; D008202:Lymphangioma / Q000517:prevention & control*; D008207:Lymphatic Metastasis; D010388:Pelvis; D011183:Postoperative Complications / Q000517:prevention & control*; D013927:Thrombosis / Q000517:prevention & control; D002583:Uterine Cervical Neoplasms / Q000601:surgery*; D014594:Uterine Neoplasms / Q000601:surgery*
D000925:Anticoagulants; D003374:Coumarins; D003911:Dextrans; C006871:calcium heparin; D006493:Heparin; C030123:coumarin